Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Moschetta

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
International Journal of Molecular Sciences|September 28, 2021
Genetic Aberrations of DNA Repair Pathways in Prostate Cancer: Translation to the ClinicAruni Ghose, Michele Moschetta, George Pappas-Gogos, et al.
European Journal of Cancer (Oxford, England : 1990)|August 31, 2010
Interleukin-1β regulates the migratory potential of MDAMB231 breast cancer cells through the hypoxia-inducible factor-1αAntonella Naldini, Irene Filippi, Diego Miglietta, et al.
International Journal of Clinical and Experimental Medicine|December 14, 2012
A retrospective study of skeletal and disease-free survival benefits of zoledronic acid therapy in patients with multiple myeloma treated with novel agentsRoberto Ria, Antonia Reale, Michele Moschetta, et al.
Critical Reviews in Oncology/Hematology|December 5, 2017
Ovarian sex-cord stromal tumours and small cell tumours: Pathological, genetic and management aspectsStergios Boussios, Michele Moschetta, George Zarkavelis, et al.
Annals of Translational Medicine|January 25, 2021
Neoadjuvant treatment for newly diagnosed advanced ovarian cancer: where do we stand and where are we going?Michele Moschetta, Stergios Boussios, Elie Rassy, et al.
Experimental Hematology & Oncology|January 13, 2017
Dabrafenib and trametinib activity in a patient with BRAF V600E mutated and microsatellite instability high (MSI-H) metastatic endometrial cancerMichele Moschetta, Gabriel Mak, Joana Hauser, et al.
American Journal of Blood Research|March 21, 2012
Bone marrow angiogenesis and progression in multiple myelomaRoberto Ria, Antonia Reale, Annunziata De Luisi, et al.
Anticancer Research|February 29, 2024
Immunotherapy Combined With Standard Therapies in Head and Neck Squamous Cell Carcinoma - A Meta-analysisDaisy Eden, Aruni Ghose, Michele Moschetta, et al.
Anticancer Research|December 6, 2015
Malignant Ovarian Germ Cell Tumors in Postmenopausal Patients: The Royal Marsden Experience and Literature ReviewStergios Boussios, Ayoma Attygalle, Steve Hazell, et al.
Diagnostics (Basel, Switzerland)|August 4, 2019
Combined Strategies with Poly (ADP-Ribose) Polymerase (PARP) Inhibitors for the Treatment of Ovarian Cancer: A Literature ReviewStergios Boussios, Peeter Karihtala, Michele Moschetta, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
International Journal of Molecular Sciences|September 28, 2021
Genetic Aberrations of DNA Repair Pathways in Prostate Cancer: Translation to the ClinicAruni Ghose, Michele Moschetta, George Pappas-Gogos, et al.
European Journal of Cancer (Oxford, England : 1990)|August 31, 2010
Interleukin-1β regulates the migratory potential of MDAMB231 breast cancer cells through the hypoxia-inducible factor-1αAntonella Naldini, Irene Filippi, Diego Miglietta, et al.
International Journal of Clinical and Experimental Medicine|December 14, 2012
A retrospective study of skeletal and disease-free survival benefits of zoledronic acid therapy in patients with multiple myeloma treated with novel agentsRoberto Ria, Antonia Reale, Michele Moschetta, et al.
Critical Reviews in Oncology/Hematology|December 5, 2017
Ovarian sex-cord stromal tumours and small cell tumours: Pathological, genetic and management aspectsStergios Boussios, Michele Moschetta, George Zarkavelis, et al.
Annals of Translational Medicine|January 25, 2021
Neoadjuvant treatment for newly diagnosed advanced ovarian cancer: where do we stand and where are we going?Michele Moschetta, Stergios Boussios, Elie Rassy, et al.
Experimental Hematology & Oncology|January 13, 2017
Dabrafenib and trametinib activity in a patient with BRAF V600E mutated and microsatellite instability high (MSI-H) metastatic endometrial cancerMichele Moschetta, Gabriel Mak, Joana Hauser, et al.
American Journal of Blood Research|March 21, 2012
Bone marrow angiogenesis and progression in multiple myelomaRoberto Ria, Antonia Reale, Annunziata De Luisi, et al.
Anticancer Research|February 29, 2024
Immunotherapy Combined With Standard Therapies in Head and Neck Squamous Cell Carcinoma - A Meta-analysisDaisy Eden, Aruni Ghose, Michele Moschetta, et al.
Anticancer Research|December 6, 2015
Malignant Ovarian Germ Cell Tumors in Postmenopausal Patients: The Royal Marsden Experience and Literature ReviewStergios Boussios, Ayoma Attygalle, Steve Hazell, et al.
Diagnostics (Basel, Switzerland)|August 4, 2019
Combined Strategies with Poly (ADP-Ribose) Polymerase (PARP) Inhibitors for the Treatment of Ovarian Cancer: A Literature ReviewStergios Boussios, Peeter Karihtala, Michele Moschetta, et al.
Pageof 9